Neuphoria Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts that cover Neuphoria Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $28, which forecasts a 490.72% increase in the stock price over the next year. The lowest target is $21 and the highest is $35.

Price Target: $28 (+490.72%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$21	$28	$35	$35
Change	+343.04%	+490.72%	+638.40%	+638.40%

* Price targets were last updated on Sep 11, 2025.

Analyst Ratings

The average analyst rating for Neuphoria Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	1	2	2	2
Buy	0	0	0	0
Hold	0	0	0	0
Sell	0	0	0	0
Strong Sell	0	0	0	0
Total	1	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason McCarthy Maxim Group	Maxim Group	Strong Buy Maintains $18 → $35	Strong Buy	Maintains	$18 → $35	+638.40%	Sep 11, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $21	Strong Buy	Reiterates	$21	+343.04%	Aug 26, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $8 → $21	Strong Buy	Maintains	$8 → $21	+343.04%	Feb 4, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 15.65M

Revenue Next Year

n/a

EPS This Year

-4.92

from -0.23

EPS Next Year

-4.17

from -4.92

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027
Revenue	695.81K	4.17M	-	-	15.65M	-	-
Revenue Growth	-66.32%	499.60%	-	-	-	-	-
EPS	-0.01	-0.01	-0.01	-18.62	-0.23	-4.92	-4.17
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-2.00	-1.27
Avg	-4.92	-4.17
Low	-7.15	-5.68

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.